Imprint databases are mostly US-centric. A confident hit for another market is still a guess.

Silent tracking in the first week is normal. Scanning happens at hubs, not continuously. Currently on a fee on the statement myself.

Worth asking what specifically was measured. Pain scores move with mood and function does not.

Reference ranges differ between labs, so comparing two reports is close to meaningless. Not on hydrocodone but the pattern is familiar.

I would stop trying to convey how bad it is and start saying what you want them to do.

A plausible mechanism is not an outcome, and this class is the textbook example. Currently on oxandrolone myself.

You have two changes at once here. You cannot attribute anything until one of them moves.

The hologram is the least useful check because it is the one everybody makes.